Half-year report · HY
4208.TEDINET S100X0R8
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥212.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥486.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥243.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥8.3bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥6.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥15.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥22.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥14.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.9bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥318m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥613m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥865.8bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥865.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥796.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥441.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥453.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥424.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥412.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥420.4bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥44.7bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥116.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥44.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥115.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥31.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥88.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥63.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥33.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥16.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥105.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥19.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥112.08 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.6 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.28 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥112.06 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥3.27 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥16.7bn |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥23.6bn |
| Otherother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥6.9bn |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥2.1bn |
| High Performance Urethansreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥17.0bn |
| High Performance Urethansreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥16.8bn |
| High Performance Urethansreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥256m |
| High Performance Urethansreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥565m |
| Machinery And Metal Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥29.8bn |
| Machinery And Metal Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥29.6bn |
| Machinery And Metal Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥138m |
| Machinery And Metal Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Pharmaceuticalreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥10.5bn |
| Pharmaceuticalreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥10.5bn |
| Pharmaceuticalreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Pharmaceuticalreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥483m |
| Polymers And Chemicalsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥118.5bn |
| Polymers And Chemicalsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥107.5bn |
| Polymers And Chemicalsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥11.0bn |
| Polymers And Chemicalsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.2bn |
| Specialty Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥29.8bn |
| Specialty Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥24.7bn |
| Specialty Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5.1bn |
| Specialty Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.3bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥222.3bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥212.7bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥9.6bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥10.3bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥20.7bn |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥25.0bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥4.4bn |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥13.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥13.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| High Performance Urethansreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥7.4bn |
| High Performance Urethansreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥7.1bn |
| High Performance Urethansreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥229m |
| High Performance Urethansreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥774m |
| Machinery And Metal Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥43.0bn |
| Machinery And Metal Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥42.8bn |
| Machinery And Metal Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥282m |
| Machinery And Metal Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Pharmaceuticalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥15.9bn |
| Pharmaceuticalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥15.0bn |
| Pharmaceuticalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥815m |
| Pharmaceuticalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥712m |
| Polymers And Chemicalsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥137.8bn |
| Polymers And Chemicalsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥128.7bn |
| Polymers And Chemicalsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥9.1bn |
| Polymers And Chemicalsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥2.5bn |
| Specialty Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥31.7bn |
| Specialty Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥24.4bn |
| Specialty Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Specialty Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥5.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥256.4bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥243.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥8.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 574
| Item | Context | Value | Unit |
|---|---|---|---|
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)株式会社東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口）※１ | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１丁目８番１号 赤坂インターシティＡＩＲ | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口）※１ | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８番12号 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)住友生命保険相互会社（常任代理人 株式会社日本カストディ銀行） | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都中央区八重洲２丁目２番１号（東京都中央区晴海１丁目８番12号） | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)日本生命保険相互会社（常任代理人 日本マスタートラスト信託銀行株式会社） | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目６番６号日本生命証券管理部内（東京都港区赤坂１丁目８番１号 赤坂インターシティＡＩＲ） | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)野村信託銀行株式会社（投信口）※１ | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町２丁目２番２号 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)株式会社山口銀行（常任代理人 日本マスタートラスト信託銀行株式会社） | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)山口県下関市竹崎町４丁目２番36号（東京都港区赤坂１丁目８番１号 赤坂インターシティＡＩＲ） | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)JP MORGAN CHASE BANK 385781（常任代理人 株式会社みずほ銀行決済営業部） | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)農林中央金庫 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町１丁目２番１号 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)単元株式数 100株 | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)同上 | |
| Description issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | Original text (Japanese)１単元（100株）未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)ＵＢＥ株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)山口県宇部市大字小串1978番96号 | |
| Name of shareholder treasury shares etc | InterimInstant_Row2Member | Original text (Japanese)株式会社木村製作所 | |
| Address of shareholder treasury shares etc | InterimInstant_Row2Member | Original text (Japanese)兵庫県加古郡稲美町六分一字百丁歩1362番66号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |